Sydney Stanley

912 total citations
14 papers, 602 citations indexed

About

Sydney Stanley is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Sydney Stanley has authored 14 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Immunology. Recurrent topics in Sydney Stanley's work include HIV Research and Treatment (6 papers), Tuberculosis Research and Epidemiology (4 papers) and Immune Cell Function and Interaction (4 papers). Sydney Stanley is often cited by papers focused on HIV Research and Treatment (6 papers), Tuberculosis Research and Epidemiology (4 papers) and Immune Cell Function and Interaction (4 papers). Sydney Stanley collaborates with scholars based in United States and Portugal. Sydney Stanley's co-authors include Kent J. Weinhold, H. Kim Lyerly, Thomas J. Matthews, Douglas S. Tyler, Dani P. Bolognesi, D P Bolognesi, John Bartlett, Chet Nastala, Kimo C. Stine and A J Langlois and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Sydney Stanley

14 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sydney Stanley United States 9 354 312 212 157 120 14 602
Florence Boudet France 12 227 0.6× 277 0.9× 162 0.8× 170 1.1× 156 1.3× 25 566
Susan Pereira Ribeiro United States 16 390 1.1× 364 1.2× 209 1.0× 165 1.1× 178 1.5× 29 740
Deepika Bhullar United States 5 252 0.7× 310 1.0× 115 0.5× 83 0.5× 213 1.8× 5 549
Zachary Ende United States 10 237 0.7× 303 1.0× 165 0.8× 238 1.5× 155 1.3× 15 664
Nicholas Francella United States 11 128 0.4× 127 0.4× 137 0.6× 86 0.5× 116 1.0× 12 411
Kim L. Weisgrau United States 12 325 0.9× 243 0.8× 175 0.8× 126 0.8× 61 0.5× 22 488
Beatriz Pacheco United States 17 743 2.1× 371 1.2× 461 2.2× 277 1.8× 212 1.8× 32 1.0k
Kelly E. Seaton United States 15 219 0.6× 263 0.8× 170 0.8× 86 0.5× 137 1.1× 29 566
Sean Matthew McCauley United States 10 457 1.3× 282 0.9× 323 1.5× 179 1.1× 281 2.3× 11 808
Sharon Lederer United States 8 327 0.9× 337 1.1× 158 0.7× 252 1.6× 211 1.8× 8 782

Countries citing papers authored by Sydney Stanley

Since Specialization
Citations

This map shows the geographic impact of Sydney Stanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sydney Stanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sydney Stanley more than expected).

Fields of papers citing papers by Sydney Stanley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sydney Stanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sydney Stanley. The network helps show where Sydney Stanley may publish in the future.

Co-authorship network of co-authors of Sydney Stanley

This figure shows the co-authorship network connecting the top 25 collaborators of Sydney Stanley. A scholar is included among the top collaborators of Sydney Stanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sydney Stanley. Sydney Stanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Stanley, Sydney, Xin Wang, Qingyun Liu, et al.. (2024). Ongoing evolution of the Mycobacterium tuberculosis lactate dehydrogenase reveals the pleiotropic effects of bacterial adaption to host pressure. PLoS Pathogens. 20(2). e1012050–e1012050. 6 indexed citations
3.
Liu, Qingyun, Junhao Zhu, Charles L. Dulberger, et al.. (2022). Tuberculosis treatment failure associated with evolution of antibiotic resilience. Science. 378(6624). 1111–1118. 46 indexed citations
4.
Stanley, Sydney, Qingyun Liu, & Sarah M. Fortune. (2022). Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine. Frontiers in Cellular and Infection Microbiology. 12. 1007958–1007958. 7 indexed citations
5.
Hicks, Nathan, Peter H. Culviner, Michael C. Chao, et al.. (2020). Mutations in dnaA and a cryptic interaction site increase drug resistance in Mycobacterium tuberculosis. PLoS Pathogens. 16(11). e1009063–e1009063. 20 indexed citations
6.
Beachboard, Dia C., Madhuvanthi Vijayan, Graham D. Williams, et al.. (2019). The small GTPase RAB1B promotes antiviral innate immunity by interacting with TNF receptor–associated factor 3 (TRAF3). Journal of Biological Chemistry. 294(39). 14231–14240. 20 indexed citations
7.
Hastings, Andrew K., Ryuta Uraki, Hallie Gaitsch, et al.. (2019). Aedes aegypti NeSt1 Protein Enhances Zika Virus Pathogenesis by Activating Neutrophils. Journal of Virology. 93(13). 54 indexed citations
8.
Tyler, Douglas S., Sydney Stanley, John Bartlett, Dani P. Bolognesi, & Kent J. Weinhold. (1998). Lymphokine-Activated Killer (LAK) Cell Anti-HIV-1 ADCC Reactivity: A Potential Strategy for Reduction of Virus-Infected Cellular Reservoirs. Journal of Surgical Research. 79(2). 115–120. 3 indexed citations
9.
Wikstrand, Carol J., Sydney Stanley, Peter A. Humphrey, et al.. (1993). Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas. Journal of Neuroimmunology. 46(1-2). 165–173. 24 indexed citations
10.
Tyler, Douglas S., et al.. (1991). The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals. Cellular Immunology. 136(1). 165–172. 6 indexed citations
11.
Tyler, Douglas S., Sydney Stanley, Susan Zolla‐Pazner, et al.. (1990). Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies.. The Journal of Immunology. 145(10). 3276–3282. 86 indexed citations
12.
Tyler, Douglas S., Sydney Stanley, John Bartlett, et al.. (1990). Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.. The Journal of Immunology. 144(9). 3375–3384. 85 indexed citations
13.
Weinhold, Kent J., et al.. (1989). HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.. The Journal of Immunology. 142(9). 3091–3097. 170 indexed citations
14.
Tyler, Douglas S., Chet Nastala, Sydney Stanley, et al.. (1989). GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.. The Journal of Immunology. 142(4). 1177–1182. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026